SG Americas Securities LLC Boosts Stock Holdings in Cardinal Health, Inc. $CAH

SG Americas Securities LLC grew its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 57.7% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,147,406 shares of the company’s stock after buying an additional 419,895 shares during the quarter. SG Americas Securities LLC owned 0.49% of Cardinal Health worth $242,458,000 at the end of the most recent quarter.

Several other large investors have also recently modified their holdings of CAH. Vanguard Group Inc. grew its position in Cardinal Health by 2.0% during the 4th quarter. Vanguard Group Inc. now owns 31,441,258 shares of the company’s stock worth $6,461,179,000 after acquiring an additional 617,775 shares during the last quarter. State Street Corp lifted its position in Cardinal Health by 1.8% in the fourth quarter. State Street Corp now owns 12,509,230 shares of the company’s stock valued at $2,570,647,000 after purchasing an additional 221,497 shares during the last quarter. Geode Capital Management LLC lifted its position in Cardinal Health by 0.7% in the fourth quarter. Geode Capital Management LLC now owns 6,529,013 shares of the company’s stock valued at $1,336,750,000 after purchasing an additional 43,924 shares during the last quarter. Wellington Management Group LLP boosted its stake in shares of Cardinal Health by 153.2% during the third quarter. Wellington Management Group LLP now owns 5,804,090 shares of the company’s stock valued at $911,010,000 after purchasing an additional 3,511,579 shares during the period. Finally, Norges Bank purchased a new stake in shares of Cardinal Health during the fourth quarter valued at approximately $790,344,000. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Cardinal Health Stock Performance

CAH opened at $222.08 on Monday. Cardinal Health, Inc. has a 52-week low of $137.75 and a 52-week high of $233.60. The stock has a market capitalization of $52.01 billion, a PE ratio of 33.96, a price-to-earnings-growth ratio of 1.21 and a beta of 0.52. The stock’s 50 day moving average price is $204.34 and its 200-day moving average price is $209.28.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Thursday, April 30th. The company reported $3.17 EPS for the quarter, topping analysts’ consensus estimates of $2.79 by $0.38. The company had revenue of $60.94 billion during the quarter, compared to analyst estimates of $62.10 billion. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The firm’s revenue was up 11.0% on a year-over-year basis. During the same quarter last year, the firm posted $2.35 earnings per share. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. Research analysts forecast that Cardinal Health, Inc. will post 10.76 EPS for the current fiscal year.

Cardinal Health Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be given a $0.5158 dividend. The ex-dividend date of this dividend is Wednesday, July 1st. This represents a $2.06 annualized dividend and a dividend yield of 0.9%. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s dividend payout ratio is 31.19%.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on CAH. William Blair initiated coverage on shares of Cardinal Health in a research note on Tuesday, April 28th. They issued an “outperform” rating on the stock. Zacks Research cut shares of Cardinal Health from a “strong-buy” rating to a “hold” rating in a research report on Friday, June 12th. Morgan Stanley raised their price target on shares of Cardinal Health from $245.00 to $255.00 and gave the stock an “overweight” rating in a report on Tuesday, April 28th. Wall Street Zen cut shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a research report on Monday, June 15th. Finally, Barclays upped their price objective on shares of Cardinal Health from $243.00 to $258.00 and gave the company an “overweight” rating in a research note on Tuesday, February 24th. Fourteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $246.93.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.